⌘K

Login Start Free

Home/Filings/4/0001437749-21-003101

4//SEC Filing

Latkin Jed 4

Accession 0001437749-21-003101

CIK 0000810509other

View on SEC.gov Company Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:08 PM ET

Size

5.9 KB

Accession

0001437749-21-003101

Insider Transaction Report

Form 4

Period: 2021-02-15

NAVIDEA BIOPHARMACEUTICALS, INC.NAVB

Interim COO

Transactions

Award
Stock Option
2021-02-15$0.00/sh+100,000$100→ 100,000 total
Exercise: $2.56Exp: 2031-02-15→ Common Stock (100,000 underlying)

Holdings

Common Stock
(indirect: By 401(k))
10,600

Footnotes (1)

[F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1

filerCIK 0001554593

Filing Metadata

Form type: 4
Filed: Feb 16, 7:00 PM ET
Accepted: Feb 17, 4:08 PM ET
Size: 5.9 KB

View on SEC.gov